The selective serotonin reuptake inhibitor fluoxetine improves glucose homeostasis by promoting insulin secretion and maintaining functional β-cell mass
Liu, B., Ruz-Maldonado, I., Zariwala, M., Huang, G.C., Zhao, M., Jones, P.M. and Persaud, S.J. 2017. The selective serotonin reuptake inhibitor fluoxetine improves glucose homeostasis by promoting insulin secretion and maintaining functional β-cell mass. European Association for the Study of Diabetes. Lisbon, Portugal Sep - Oct 2017 Springer. https://doi.org/10.1007/s00125-017-4350-z